Verrica Pharmaceuticals buy Needham & Company LLC
Start price
10.11.23
/
50%
€2.74
Target price
10.11.24
€7.49
Performance (%)
-71.24%
End price
11.11.24
€0.79
Summary
This prediction ended on 11.11.24 with a price of €0.79. Massive losses of -71.24% were the result for the BUY prediction by Needham___Company_LL. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Verrica Pharmaceuticals | - | - | - |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% |
Comments by Needham___Company_LL for this prediction
In the thread Discuss Verrica Pharmaceuticals
Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its price target lowered by analysts at Needham & Company LLC from $10.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for VRCA provided by MarketBeat
In the thread Trading Verrica Pharmaceuticals
Die von Needham___Company_LL gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Needham___Company_LL for Verrica Pharmaceuticals
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€2.62
15.08.24
15.08.24
€10.95
15.08.25
15.08.25
-77.18%
16.08.25
16.08.25
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€9.90
14.05.24
14.05.24
€14.81
14.05.25
14.05.25
-95.10%
15.05.25
15.05.25
Verrica Pharmaceuticals
Start price
Target price
Perf. (%)
€3.90
23.08.23
23.08.23
€9.25
23.08.24
23.08.24
-38.46%
24.08.24
24.08.24